Myriad Genetics Inc (MYGN)

CapEx to Revenue

1.10%

Quarterly · Period ending:

MYGN logo

MYGN CapEx to Revenue

Latest reported1.10%
MYGN Quarterly CapEx/Revenue (0.00% → 1.10%)
High-resolution chart · PNG

MYGN capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
11.3685%
12.1687%
10.3412%
12.7657%
12.7028%
19.0839%
8.4337%
13.0435%
8.6957%
21.2401%
15.7895%
17.8571%
16.9231%
12.2807%
13.7255%
11.8644%
9.3333%
51.8519%
35.7143%
72.7273%
50%
115.7895%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.